Brief: SMS Lifesciences India Deferred Issue Of NCDs
08/02/2018 10:42
Feb 8 (Reuters) - SMS Lifesciences India Ltd SMSL.NS :
* BOARD DEFERRED ISSUE OF NON-CONVERTIBLE PREFERENCE SHARES
OR
NON-CONVERTIBLE DEBENTURES ON PREFERENTIAL BASIS
Source text - http://bit.ly/2GYButT
Further company coverage: SMSL.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls